Gilead Sciences, Inc’s filing revealed that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.1 million on Dec 19 ’24. In the deal valued at $21.37 per share,940,499 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 2,209,471 shares worth roughly $198.72 million.
Then, GILEAD SCIENCES, INC. bought 1,759,978 shares, generating $1,830,377 in total proceeds. Upon buying the shares at $1.04, the 10% Owner now owns 9,105,451 shares.
Before that, Dickinson Andrew D sold 8,500 shares. Gilead Sciences, Inc shares valued at $781,660 were divested by the Chief Financial Officer at a price of $91.96 per share. As a result of the transaction, Dickinson Andrew D now holds 132,373 shares, worth roughly $11.91 million.
Morgan Stanley upgraded its Gilead Sciences, Inc [GILD] rating to an Overweight from a an Equal-weight in a research note published on January 10, 2025; the price target was increased to $113 from $87. Wolfe Research began covering GILD with “an Outperform” recommendation on November 15, 2024. Citigroup started covering the stock on November 14, 2024. It rated GILD as “a Buy”.
Price Performance Review of GILD
On Monday, Gilead Sciences, Inc [NASDAQ:GILD] saw its stock jump 0.07% to $89.94. Over the last five days, the stock has lost -1.61%. Gilead Sciences, Inc shares have fallen nearly -2.63% since the year began. Nevertheless, the stocks have risen 6.44% over the past one year. While a 52-week high of $98.90 was reached on 01/02/25, a 52-week low of $62.07 was recorded on 01/10/25. SMA at 50 days reached $91.71, while 200 days put it at $78.15.
Levels Of Support And Resistance For GILD Stock
The 24-hour chart illustrates a support level at 89.18, which if violated will result in even more drops to 88.43. On the upside, there is a resistance level at 90.53. A further resistance level may holdings at 91.13. The Relative Strength Index (RSI) on the 14-day chart is 42.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.09%. Stochastics %K at 15.78% indicates the stock is a buying.
How much short interest is there in Gilead Sciences, Inc?
A steep rise in short interest was recorded in Gilead Sciences, Inc stocks on 2024-12-31, growing by 2.24 million shares to a total of 25.66 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 23.41 million shares. There was a rise of 8.74%, which implies that there is a positive sentiment for the stock.
